Skip to content
Study details
Enrolling now

BE WELL With Migraine: Brain Education and WELLness With Migraine

Wake Forest University Health Sciences
NCT IDNCT05987592ClinicalTrials.gov data as of Apr 2026
Target enrollment

286

Study length

about 2.9 years

Ages

18+

Locations

3 sites in MA, NC, OH

About this study

This trial is testing two different non-drug, virtual treatment options designed to improve the lives of patients with migraine. Both interventions involve 8 weekly sessions and an online platform with additional content and learning. Participants can stay on all their medications during it.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Participate in Brain Education and WELLness with Migraine Group A
  • 2.Participate in Brain Education and WELLness with Migraine Group B

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low6%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Secondary: Anxiety assessed using Generalized Anxiety Disorder-7 (GAD-7) at 8 weeks - Change in anxiety from baseline to 8 weeks, Depression assessed using Patient Health Questionnaire (PHQ-8) Questionnaire - Change in Depression from baseline to 8 weeks, Pain Catastrophizing quantified using Pain Catastrophizing Scale (PCS) - Change in Pain catastrophizing from baseline to 8 weeks, Quality of Life assessed using Migraine Specific Quality of Life version 2.1 (MSQL v2.1) at 8 weeks, Self-Efficacy assessed with the Headache Management Self-Efficacy Scale (HMSE) - Change in Self-efficacy from baseline to 8 weeks

Body systems

Neurology